title: Specific and nonspecific immunity in the prevention of spontaneous tumours.
abstract: Antitumour vaccines cannot cure established tumours. However, tumour cells engineered to release cytokines can halt progression to cancer by inhibiting the angiogenic phenotype of pretumoural cells and activating tumour-associated leukocytes, thus they might prove useful in immunizing those at risk of cancer.
authors.affiliation: Istituto di Cancerologia, Viale Filopanti 22, 40126 Bologna, Italy.
authors.forename: P L
authors.initials: PL
authors.lastname: Lollini
authors.forename: G
authors.initials: G
authors.lastname: Forni
mesh_terms: D000818:Animals; D019496:Cancer Vaccines / Q000494:pharmacology; D016207:Cytokines / Q000494:pharmacology; D006801:Humans; D009369:Neoplasms / Q000235:genetics / Q000276:immunology* / Q000517:prevention & control*; D009389:Neovascularization, Pathologic / Q000276:immunology / Q000517:prevention & control
chemical_list: D019496:Cancer Vaccines; D016207:Cytokines